Your browser doesn't support javascript.
loading
Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation.
Madeo, Simona F; Zagaroli, Luca; Vandelli, Sara; Calcaterra, Valeria; Crinò, Antonino; De Sanctis, Luisa; Faienza, Maria Felicia; Fintini, Danilo; Guazzarotti, Laura; Licenziati, Maria Rosaria; Mozzillo, Enza; Pajno, Roberta; Scarano, Emanuela; Street, Maria E; Wasniewska, Malgorzata; Bocchini, Sarah; Bucolo, Carmen; Buganza, Raffaele; Chiarito, Mariangela; Corica, Domenico; Di Candia, Francesca; Francavilla, Roberta; Fratangeli, Nadia; Improda, Nicola; Morabito, Letteria A; Mozzato, Chiara; Rossi, Virginia; Schiavariello, Concetta; Farello, Giovanni; Iughetti, Lorenzo; Salpietro, Vincenzo; Salvatoni, Alessandro; Giordano, Mara; Grugni, Graziano; Delvecchio, Maurizio.
Afiliação
  • Madeo SF; Department of Medical and Surgical Sciences for Mother, Children and Adults, Pediatric Unit, University of Modena and Reggio Emilia, Modena, Italy.
  • Zagaroli L; Department of Pediatrics, University of L'Aquila, L'Aquila, Italy.
  • Vandelli S; Department of Medical and Surgical Sciences for Mother, Children and Adults, Post-Graduate School of Pediatrics, University of Modena and Reggio Emilia, Modena, Italy.
  • Calcaterra V; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
  • Crinò A; Pediatric Department, Buzzi Children's Hospital, Milano, Italy.
  • De Sanctis L; Center for Rare Diseases and Congenital Defects, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
  • Faienza MF; Pediatric Endocrinology, Regina Margherita Children Hospital - Department of Public Health and Pediatric Sciences, University of Torino, Torino, Italy.
  • Fintini D; Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", Bari, Italy.
  • Guazzarotti L; Prader Willi Reference Center, Endocrinology and Diabetology Unit, Pediatric University Department, IRCCS Bambino Gesù Children Hospital, Rome, Italy.
  • Licenziati MR; Pediatric Endocrinology Unit, University Hospital of Padova, Padova, Italy.
  • Mozzillo E; Neuro-endocrine Diseases and Obesity Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
  • Pajno R; Department of Translational and Medical Science, Section of Pediatrics, University of Naples Federico II, Naples, Italy.
  • Scarano E; Pediatric Unit, IRCCS San Raffaele Institute, Milan, Italy.
  • Street ME; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Wasniewska M; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Bocchini S; Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.
  • Bucolo C; Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy.
  • Buganza R; Pediatric Unit, Gaetano Martino University Hospital of Messina, Messina, Italy.
  • Chiarito M; Prader Willi Reference Center, Endocrinology and Diabetology Unit, Pediatric University Department, IRCCS Bambino Gesù Children Hospital, Rome, Italy.
  • Corica D; Pediatric Unit, IRCCS San Raffaele Institute, Milan, Italy.
  • Di Candia F; Pediatric Endocrinology, Regina Margherita Children Hospital - Department of Public Health and Pediatric Sciences, University of Torino, Torino, Italy.
  • Francavilla R; Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", Bari, Italy.
  • Fratangeli N; Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy.
  • Improda N; Pediatric Unit, Gaetano Martino University Hospital of Messina, Messina, Italy.
  • Morabito LA; Department of Translational and Medical Science, Section of Pediatrics, University of Naples Federico II, Naples, Italy.
  • Mozzato C; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Rossi V; Division of Auxology, Istituto Auxologico Italiano, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Verbania, Italy.
  • Schiavariello C; Neuro-endocrine Diseases and Obesity Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
  • Farello G; Pediatric Unit, Gaetano Martino University Hospital of Messina, Messina, Italy.
  • Iughetti L; Child and Women Health Department, University of Padova, Padova, Italy.
  • Salpietro V; Pediatric Department, Buzzi Children's Hospital, Milano, Italy.
  • Salvatoni A; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Giordano M; Department of Clinical Medicine, Public Health, Life and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Grugni G; Department of Medical and Surgical Sciences for Mother, Children and Adults, Pediatric Unit, University of Modena and Reggio Emilia, Modena, Italy.
  • Delvecchio M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Front Endocrinol (Lausanne) ; 15: 1382583, 2024.
Article em En | MEDLINE | ID: mdl-38737552
ABSTRACT
Prader-Willi syndrome (PWS) is a complex genetic disorder caused by three different types of molecular genetic abnormalities. The most common defect is a deletion on the paternal 15q11-q13 chromosome, which is seen in about 60% of individuals. The next most common abnormality is maternal disomy 15, found in around 35% of cases, and a defect in the imprinting center that controls the activity of certain genes on chromosome 15, seen in 1-3% of cases. Individuals with PWS typically experience issues with the hypothalamic-pituitary axis, leading to excessive hunger (hyperphagia), severe obesity, various endocrine disorders, and intellectual disability. Differences in physical and behavioral characteristics between patients with PWS due to deletion versus those with maternal disomy are discussed in literature. Patients with maternal disomy tend to have more frequent neurodevelopmental problems, such as autistic traits and behavioral issues, and generally have higher IQ levels compared to those with deletion of the critical PWS region. This has led us to review the pertinent literature to investigate the possibility of establishing connections between the genetic abnormalities and the endocrine disorders experienced by PWS patients, in order to develop more targeted diagnostic and treatment protocols. In this review, we will review the current state of clinical studies focusing on endocrine disorders in individuals with PWS patients, with a specific focus on the various genetic causes. We will look at topics such as neonatal anthropometry, thyroid issues, adrenal problems, hypogonadism, bone metabolism abnormalities, metabolic syndrome resulting from severe obesity caused by hyperphagia, deficiencies in the GH/IGF-1 axis, and the corresponding responses to treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Prader-Willi / Estudos de Associação Genética Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Prader-Willi / Estudos de Associação Genética Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália
...